Related Experiment Videos
Pap test results. Responding to Bethesda system reports
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario.
Canadian Family Physician Medecin De Famille Canadien
|August 10, 2001
Summary
The Bethesda System for Pap test results guides cervical cancer screening management. Adequacy and diagnostic categories determine follow-up, ensuring appropriate patient care for abnormal Pap smears.
Area of Science:
- Gynecologic Pathology
- Cervical Cancer Screening
- Cytopathology
Background:
- The Bethesda System (TBS) is the standard for reporting cervicovaginal cytology.
- Effective management of Pap test results relies on understanding TBS adequacy and diagnostic categories.
Purpose of the Study:
- To review the adequacy and diagnostic categories of the Bethesda System for Pap test reporting.
- To summarize evidence-based management options for various Pap test results.
Main Methods:
- Review of current research evidence and guidelines from international and Canadian sources.
- Synthesis of management strategies based on TBS adequacy and diagnostic classifications.
Main Results:
- Unsatisfactory Pap smears require retesting.
- Normal or benign cellular changes (WNL/BCC) on satisfactory smears necessitate routine screening intervals.
- High-grade squamous intraepithelial lesions (HSIL), atypical glandular cells (AGUS), or malignancy require colposcopy.
- Management for atypical squamous cells of uncertain significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL) remains debated.
Conclusions:
- Pap test management is dictated by both the adequacy of the specimen and the cytological diagnosis.
- Standardized reporting and evidence-based guidelines improve cervical cancer screening outcomes.